Communiqués de presse d'Aji Bio-Pharma Communiqués de presse December 18, 2018 Ajinomoto and XL-protein forge Strategic Alliance to develop PASylated therapeutics applying the CORYNEX® platform En savoir plus November 28, 2018 Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing En savoir plus October 23, 2018 Precision NanoSystems Announces Manufacturing Collaboration Agreement with Ajinomoto Bio-Pharma Services for GMP Manufacturing of High Quality Nanomedicines En savoir plus October 2, 2018 Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry En savoir plus April 14, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing En savoir plus April 13, 2017 Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Manufacturing En savoir plus December 18, 2016 Ajinomoto Group Acquires All Shares of GeneDesign, a Nucleic Acid Drug CDMO, to Accelerate Expansion of the Contract Business for Oligonucleotides. En savoir plus
